0001209191-20-001784.txt : 20200106
0001209191-20-001784.hdr.sgml : 20200106
20200106162054
ACCESSION NUMBER: 0001209191-20-001784
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200102
FILED AS OF DATE: 20200106
DATE AS OF CHANGE: 20200106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gaspar Bobby
CENTRAL INDEX KEY: 0001793992
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38722
FILM NUMBER: 20509963
MAIL ADDRESS:
STREET 1: ORCHARD THERAPEUTICS PLC
STREET 2: 108 CANNON STREET
CITY: LONDON
STATE: X0
ZIP: EC4N 6EU
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orchard Therapeutics plc
CENTRAL INDEX KEY: 0001748907
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: 108 CANNON STREET
CITY: LONDON
STATE: X0
ZIP: EC4N 6EU
BUSINESS PHONE: 011-44-0-203-3846700
MAIL ADDRESS:
STREET 1: 108 CANNON STREET
CITY: LONDON
STATE: X0
ZIP: EC4N 6EU
FORMER COMPANY:
FORMER CONFORMED NAME: Orchard Rx Ltd
DATE OF NAME CHANGE: 20180802
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-02
0
0001748907
Orchard Therapeutics plc
ORTX
0001793992
Gaspar Bobby
C/O ORCHARD THERAPEUTICS PLC
108 CANNON STREET
LONDON
X0
EC4N 6EU
UNITED KINGDOM
1
1
0
0
See Remarks
Stock Option (Right to Buy)
13.58
2020-01-02
4
A
0
200000
0.00
A
2030-01-01
Ordinary Shares
200000
200000
D
The shares subject to this option vest in equal monthly installments over the four years after January 2, 2020.
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Title: President of Research and Chief Scientific Officer
/s/ Frank E. Thomas, attorney-in-fact for Bobby Gaspar
2020-01-06